Search

Author/Creator Espiritu, L.

1. Phase 1/2 study of the safety and efficacy of APL-101, a specific c-MET inhibitor. (October 2020)

Authors:
Kizilbash, S.H.; El-Khoueiry, A.; Lerner, R.E.; Ma, P.C.; Almubarak, M.; Mody, K.; Burkard, M.E.; Guarino, M.; Jenab-Wolcott, J.; Sankar, N.; Choy, G.; Espiritu, L.; Zhang, X.; Luria, A.; Benedetti, F.; Dees, E.C.
Journal:
European journal of cancer
Issue:
Volume 138(2020)Supplement 2
Page Start:
S11
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search